BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37699645)

  • 1. Utility of
    Chandekar KR; Satapathy S; Sharma A; Taneja N; Tripathi M; Bal C
    J Nucl Med Technol; 2023 Dec; 51(4):335-336. PubMed ID: 37699645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FDG PET/CT in Xanthoma Disseminatum.
    Arslan E; Aksoy T; Leblebici C; Koku-Aksu AE; Çermik TF
    Clin Nucl Med; 2020 Sep; 45(9):681-682. PubMed ID: 32657869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of FDG-PET/CT imaging in the evaluation of multicentric reticulohistiocytosis: A case report.
    Asano T; Suzutani K; Watanabe A; Honda A; Mori N; Yashiro M; Sato S; Kobayashi H; Watanabe H; Hazama M; Kanno T; Suzuki E; Ishii S; Migita K
    Medicine (Baltimore); 2018 Aug; 97(33):e11449. PubMed ID: 30113451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic Multicentric Reticulohistiocytosis on 18F-FDG PET/CT Breast Carcinoma Follow-up.
    Dietz M; Debarbieux S; Righetti M; Harou O; Tordo J
    Clin Nucl Med; 2021 May; 46(5):e253-e255. PubMed ID: 33323726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of xanthoma disseminatum: evaluation and monitoring by 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Jin S; Chae SY; Chang SE; Suh C; Lee SW; Ryu JS
    Br J Dermatol; 2014 May; 170(5):1177-81. PubMed ID: 24329687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Xanthoma disseminatum with asymptomatic multisystem involvement].
    Zinoun M; Hali F; Marnissi F; Lazaar S; Benchikhi H
    Ann Dermatol Venereol; 2015 Apr; 142(4):276-80. PubMed ID: 25626620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xanthoma Disseminatum Presenting with Hoarseness.
    Behera B; Malathi M; Thappa DM; Vamanshankar H; Parida PK; Gochhait D
    Iran J Otorhinolaryngol; 2017 Nov; 29(95):365-368. PubMed ID: 29383319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of
    Albano D; Bosio G; Giubbini R; Bertagna F
    Jpn J Radiol; 2017 Oct; 35(10):574-583. PubMed ID: 28748503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete metabolic response to therapy of hepatic epithelioid hemangioendothelioma evaluated with 18F-fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography: A CARE case report.
    Giancipoli RG; Monti S; Basturk O; Klimstra D; Keohan ML; Schillaci O; Corrias G; Sawan P; Mannelli L
    Medicine (Baltimore); 2018 Oct; 97(42):e12795. PubMed ID: 30334971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of
    Jitani AK; Dutta S; Mandal PK; De R; Jajodia E; Baul S; Chakrabarti P; Dolai TK
    Indian J Med Res; 2021 May; 154(5):691-698. PubMed ID: 35532587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthoma disseminatum in an infant with skeletal and marrow involvement.
    Calverly DC; Wismer J; Rosenthal D; deSa D; Barr RD
    J Pediatr Hematol Oncol; 1995 Feb; 17(1):61-5. PubMed ID: 7743240
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Obert J; Vercellino L; Van Der Gucht A; de Margerie-Mellon C; Bugnet E; Chevret S; Lorillon G; Tazi A
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):598-610. PubMed ID: 27645693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG PET/CT Findings in Multicentric Reticulohistiocytosis.
    Zhang B; Zhou H; Han J; Shi X; Zhang X
    Clin Nucl Med; 2016 Apr; 41(4):333-5. PubMed ID: 26571445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necrobiotic Xanthogranuloma on 18F-FDG PET/CT.
    Eltilib M; Fenner J; Saramago I; Oldan J
    Clin Nucl Med; 2020 Dec; 45(12):967-969. PubMed ID: 32969908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthoma disseminatum: effective therapy with 2-chlorodeoxyadenosine in a case series.
    Khezri F; Gibson LE; Tefferi A
    Arch Dermatol; 2011 Apr; 147(4):459-64. PubMed ID: 21173305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of FDG PET/CT in the Evaluation of Therapy Response in Systemic Juvenile Xanthogranuloma.
    Mavi ME; Turan BS; Salanci BV; Bozkurt MF
    Clin Nucl Med; 2022 May; 47(5):e395-e396. PubMed ID: 35085175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of
    McDonald EO; Amanullah AA; Park PSU; Song W; Werner TJ; Alavi A; Revheim ME
    Ann Nucl Med; 2023 Jun; 37(6):328-348. PubMed ID: 37095393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.